Back
iShares Emerging Markets Dividend ETF Vs. Insmed, Inc. Sector Stock Comparison
Sell
46
DVYE
iShares Emerging Markets Dividend ETF
Last Price:
$30.81
Seasonality Move:
-0.16%
Sell
46
INSM
Insmed, Inc.
Last Price:
$174.52
Seasonality Move:
7.61%
Sell
46
iShares Emerging Markets Dividend ETF (DVYE)
is a Sell
Is iShares Emerging Markets Dividend ETF a Buy, Sell or Hold?
-
The current iShares Emerging Markets Dividend ETF [DVYE] share price is $30.81. The Score for DVYE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
DVYE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $174.84. The Score for INSM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DVYE Stock Price Chart
What is iShares Emerging Markets Dividend ETF's stock price today?
-
The iShares Emerging Markets Dividend ETF share price today is $30.81The current trend is relatively stagnant and DVYE is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $174.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight buying pressure.
DVYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.47 | Sell |
| Chaikin Money Flow: | -212513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.7 - 31.28) | Sell |
| Bollinger Bands (100): | (29.39 - 30.93) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 37.6 | Sell |
| Chaikin Money Flow: | 7900670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.78 - 208.54) | Sell |
| Bollinger Bands (100): | (131.89 - 191.39) | Buy |
DVYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.85 | Sell |
| 20-day SMA: | 30.97 | Sell |
| 50-day SMA: | 30.68 | Buy |
| 200-day SMA: | 29 | Buy |
| 8-day EMA: | 30.81 | Buy |
| 20-day EMA: | 30.9 | Sell |
| 50-day EMA: | 30.68 | Buy |
| 200-day EMA: | 29.35 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 189.94 | Sell |
| 20-day SMA: | 198.55 | Sell |
| 50-day SMA: | 186.85 | Sell |
| 200-day SMA: | 121.67 | Buy |
| 8-day EMA: | 187.6 | Sell |
| 20-day EMA: | 192.95 | Sell |
| 50-day EMA: | 184.53 | Sell |
| 200-day EMA: | 136 | Buy |
iShares Emerging Markets Dividend ETF Earnings Growth & DVYE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.
iShares Emerging Markets Dividend ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||